Asmanex hfa and Epinephrine drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Asmanex hfa (mometasone furoate) and Epinephrine (epinephrine). Common drug interactions include urinary tract infection among females and dyspnoea among males.

The phase IV clinical study analyzes what interactions people have when they take Asmanex hfa and Epinephrine. It is created by eHealthMe based on reports of 25 people who take the same drugs from the FDA, and is updated regularly.

What is Asmanex hfa?

Asmanex hfa has active ingredients of mometasone furoate. eHealthMe is studying from 1,067 Asmanex hfa users. Check the latest studies of Asmanex hfa.

What is Epinephrine?

Epinephrine has active ingredients of epinephrine. It is often used in asthma. eHealthMe is studying from 21,290 Epinephrine users. Check the latest studies of Epinephrine.

On Aug, 03, 2026

25 people who take Asmanex hfa and Epinephrine together, and have interactions are studied.

Asmanex hfa and Epinephrine drug interactions.

What are the common drug interactions of Asmanex Hfa and Epinephrine, by gender? *:

female:

Urinary tract infection
Fall
Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
Infusion related reaction
Infusion site discomfort
Infusion site pain
Injection site bruising
Injection site swelling
Migraine (headache)
Nausea (feeling of having an urge to vomit)

male:

Dyspnoea (difficult or laboured respiration)
Infusion site swelling
Sinusitis (inflammation of sinus)
Swelling face

What are the common drug interactions of Asmanex Hfa and Epinephrine, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

Arthralgia (joint pain)
Dry eye (lack of adequate tears)
Eye colour change
Eye irritation
Eye pruritus (eye itching)
Oral mucosal blistering (mouth ulcer)

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
Fall
Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
Herpes zoster
Infusion related reaction
Infusion site discomfort
Infusion site pain
Injection site bruising
Injection site swelling
Malaise (a feeling of general discomfort or uneasiness)

50-59:

Fatigue (feeling of tiredness)
Injection site haemorrhage (bleeding from injection site)
Injection site irritation
Oropharyngeal pain
Pain
Syncope (loss of consciousness with an inability to maintain postural tone)
Hypotension (abnormally low blood pressure)
Influenza
Respiratory disorder (respiratory disease)
Pneumonia

60+:

Dyspnoea (difficult or laboured respiration)
Allergy to chemicals
Lymphoedema (localized fluid retention and tissue swelling)
Peripheral swelling
Pruritus (severe itching of the skin)
Sleep disorder
Eyelid infection
Swelling face
Breast cancer female
Cellulitis (infection under the skin)

What are the existing conditions these people have? *

Immunodeficiency Common Variable: 13 people, 52.00%
Primary Immunodeficiency Syndrome: 10 people, 40.00%
Immunodeficiency: 6 people, 24.00%
Eosinophilic Esophagitis (Eosinophilic esophagitis (EoE) is an allergic inflammatory condition of the esophagus that involves eosinophils, a type of white blood cell): 2 people, 8.00%

* Approximation only. Some reports may have incomplete information.

Do you take Asmanex hfa and Epinephrine?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously